These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 11449276)

  • 1. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.
    Pethe K; Alonso S; Biet F; Delogu G; Brennan MJ; Locht C; Menozzi FD
    Nature; 2001 Jul; 412(6843):190-4. PubMed ID: 11449276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis.
    Parra M; Pickett T; Delogu G; Dheenadhayalan V; Debrie AS; Locht C; Brennan MJ
    Infect Immun; 2004 Dec; 72(12):6799-805. PubMed ID: 15557600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis.
    Locht C; Hougardy JM; Rouanet C; Place S; Mascart F
    Tuberculosis (Edinb); 2006; 86(3-4):303-9. PubMed ID: 16510310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boosting with mycobacterial heparin-binding haemagglutinin enhances protection of Mycobacterium bovis BCG-vaccinated newborn mice against M. tuberculosis.
    Guerrero GG; Debrie AS; Locht C
    Vaccine; 2010 Jun; 28(27):4340-7. PubMed ID: 20447476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set.
    Sun R; Converse PJ; Ko C; Tyagi S; Morrison NE; Bishai WR
    Mol Microbiol; 2004 Apr; 52(1):25-38. PubMed ID: 15049808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and purification of recombinant methylated HBHA in Mycobacterium smegmatis.
    Delogu G; Bua A; Pusceddu C; Parra M; Fadda G; Brennan MJ; Zanetti S
    FEMS Microbiol Lett; 2004 Oct; 239(1):33-9. PubMed ID: 15451098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-binding hemagglutinin (HBHA) of Mycobacterium leprae is expressed during infection and enhances bacterial adherence to epithelial cells.
    de Lima CS; Marques MA; Debrie AS; Almeida EC; Silva CA; Brennan PJ; Sarno EN; Menozzi FD; Pessolani MC
    FEMS Microbiol Lett; 2009 Mar; 292(2):162-9. PubMed ID: 19220476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal vaccination with Mycobacterium bovis BCG: potential effects as a priming agent shown in a heterologous prime-boost immunization protocol.
    Rahman MJ; Fernández C
    Vaccine; 2009 Jun; 27(30):4038-46. PubMed ID: 19379788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterial heparin-binding hemagglutinin and laminin-binding protein share antigenic methyllysines that confer resistance to proteolysis.
    Pethe K; Bifani P; Drobecq H; Sergheraert C; Debrie AS; Locht C; Menozzi FD
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10759-64. PubMed ID: 12149464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of an in vitro model using NR8383 cells and Mycobacterium bovis Calmette-Guerin that mimics a chronic infection of Mycobacterium tuberculosis.
    Hino M; Oda M; Yoshida A; Nakata K; Kohchi C; Nishizawa T; Inagawa H; Hori H; Makino K; Terada H; Soma G
    In Vivo; 2005; 19(5):821-30. PubMed ID: 16097433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of infection model for studying intracellular gene expression of Mycobacterium tuberculosis.
    Alli OA; Ogbolu DO; Spreadbury CL
    Afr J Med Med Sci; 2009 Dec; 38(4):325-32. PubMed ID: 20499625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis.
    Masungi C; Temmerman S; Van Vooren JP; Drowart A; Pethe K; Menozzi FD; Locht C; Mascart F
    J Infect Dis; 2002 Feb; 185(4):513-20. PubMed ID: 11865404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Mycobacterium bovis intranasal challenge model in mice.
    Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ
    Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and cytoadherence of recombinant heparin binding haemagglutinin (HBHA) of Mycobacterium avium subsp. paratuberculosis: functional promiscuity or a role in virulence?
    Sechi LA; Ahmed N; Felis GE; Duprè I; Cannas S; Fadda G; Bua A; Zanetti S
    Vaccine; 2006 Jan; 24(3):236-43. PubMed ID: 16337720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
    J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.